NMPA Approval

Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell)

Approval Number

国药准字S20230022

Company兰州生物制品研究所有限责任公司

Registration Date

April 17, 2023

Drug Information

Generic Name

口服三价重配轮状病毒减毒活疫苗(Vero细胞)

Trade Name

瑞特威

Dosage Form

口服溶液剂

Strength

每瓶2.0ml，每1次人用剂量为2.0ml，所含的G2、G3和G4型人-羊轮状病毒基因重配株病毒滴度均应不低于4.5 lgCCID50/ml。

Drug Type

生物制品

Registration Date

April 17, 2023

Company Information

Applicant Company

Company Name兰州生物制品研究所有限责任公司

Company Address

兰州市城关区盐场路888号

Manufacturing Company

Company Name兰州生物制品研究所有限责任公司

Company Address

甘肃省兰州市城关区盐场路888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.